Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM)
NCT05345457Phase 4Terminated
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of azithromycin, amoxicillin in preterm premature rupture of membranes (pPROM), sponsored by University Hospitals Cleveland Medical Center. Started Jan 2023; status: terminated.
02
Drugs
azithromycinamoxicillin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT05345457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05345457.